FDA - Food and Drug Administration

11/19/2024 | Press release | Distributed by Public on 11/19/2024 11:50

Par Pharmaceutical (Clonazepam Orally Disintegrating Tablets, USP (C-IV)/Endo, Inc.) Recall reason: Mislabeled with the incorrect strength on the carton

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.